GLP-1 Market
LLY $1123.00 ▼ -0.1% NVO $44.01 ▼ -1.2% PFE $27.65 ▼ -0.5% VKTX $32.13 ▼ -1.7% KLRA $14.91 ▲ +0.5% GPCR $39.55 ▼ -4.1% RHHBY $53.19 ▼ -0.4% HIMS $27.44 ▼ -1.6% WW $14.78 ▼ -1.1%
Delayed · As of 9:20 AM

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

metformin and liraglutide

Company
University Medical Centre Ljubljana
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
None currently listed

Efficacy results: Not yet reported

No recruiting studies currently listed

See all studies for this drug

Data source: ClinicalTrials.gov · trial data as of Sep 11, 2026

Trial details
  • Completed NCT NCT01208012

    Impact of Liraglutide on Endothelial Function and Microvascular Blood Flow in Type 2 Diabetes Mellitus

    Not yet reported ikfe-CRO GmbH 44 participants Est. completion 2010-11 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01511198

    Efficacy and Safety of Metformin and Liraglutide in Obese Subjects With Type 2 Diabetes Previously Treated With an Oral Hypoglycemic Agent

    Not yet reported Novo Nordisk A/S 223 participants Est. completion 2001-10 39 sites
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01911468

    Polycystic Ovary Syndrome and Liraglutide as Add-on Therapy on Metformin

    Not yet reported University Medical Centre Ljubljana 36 participants Est. completion 2013-04 1 site
    Other conditions: PCOS, Obesity
    View official trial listing →
  • Completed NCT NCT02483299

    Liraglutide as Add on Therapy on Metformin in Women With Polycystic Ovary Syndrome

    Not yet reported University Medical Centre Ljubljana 40 participants Est. completion 2015-04 1 site
    Other conditions: PCOS, Obesity
    View official trial listing →
  • Completed NCT NCT02909933

    Low Dose Liraglutide and Metformin vs. High Dose Liraglutide Alone in Treatment of Obesity

    Not yet reported University Medical Centre Ljubljana 30 participants Est. completion 2015-10 1 site
    Other conditions: Polycystic Ovary Syndrome, Obesity
    View official trial listing →
  • Completed NCT NCT02960659

    Title: Therapeutic Targets in African-American Youth With Type 2 Diabetes

    Not yet reported, Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 24 participants Est. completion 2022-05-20 1 site
    Type 2 diabetes
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources
Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.